8-K 1 8k.txt NOTICE OF FILING VOLUNTARY SUSPENSION OF DUTY TO REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------------------------- FORM 8-K ---------------------------------------- CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report:October 20,2011 -------------------------------------- APERTURE HEALTH, INC. (Exact name of registrant specified in its charter) Nevada 000-09283 20-8085447 (State or other jurisdiction (Commission (IRS Employer incorporation or organization) File Number) Identification No.) 42583 North Coyote Road Queens Creek, AZ 85140 (Address of principal executive office) (602) 421-4464 (Registrants telephone number, including area code) Check the appropriate box below of the Form 8-K is intended to simultaneously statisy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soiciting material pursuant to Rule 14a-12 under the Exchandge Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act [ ] Pre-commencement communications pursuant to 13e-4(c) under the Exchange Act ================================================================================ Item 8.01 Other Information On October 20, 2011, the Registrant filed an Form 15 (15-12g) with the Securities and Exchange Commission ("SEC"). Believing that the Registrant had terminated its reporting obligations, the Registrant commenced filing its financials with OTC Markets.com (formerly, Pink Sheets.com). On November 16, 2011, the Registrant incorrectly filed a Form 15/A terminating the earlier filed Form 15 (15-12g), based on the number of shareholders. However, while the Company has in excess of 500 shareholders it has assets of only $236,000, well below the $10MM threshhold required under Rule 12g-4(a)(1). Accordingly, the Company is simultaneously filing Form 15 (12g-4(a)(1)) voluntarily suspending its reporting obligations with the SEC. As a result of this action, the common stock of the Company is no longer traded on the OTCQX Bulletin Board. The Company is actively seeking debt or equity financing to fund its operations, including retiring debt to allow it to continue its business development. Once adequate financing has been secured, the Company will resume its audit. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 2, 2014 APERTURE HEALTH, INC By: /s/ James Henning ------------------ James Henning Chief Exeuctive Officer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 6, 2011(December 29, 2010)

Aperture Health, Inc.

(Exact name of registrant as specified in its charter)

Nevada (State of incorporation) 000-09283 (Commission File No.) 20-8085447 (IRS Employer Identification No.)

27201 Puerta Real, Suite 350

Mission Viejo, CA 92691

(Address of principal executive offices, including zip code)

949-609-1966

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SECTION 1- REGISTRANT'S BUSINESS AND OPERATIONS

Item 1.01 Entry into a Material Definitive Agreement.

On December 29, 2010, Aperture Health, Inc., a Nevada corporation (the “Registrant”) entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with Triad Therapeutics, Inc., a Delaware corporation (“Triad”). Pursuant to the Exchange Agreement, 51% of the Registrant’s then issued and outstanding common stock, or an aggregate of 41,392,478 shares, were exchanged for all of the then issued and outstanding shares, or an aggregate of 25,215,118 shares of common stock, of Triad.

Exhibit

Number Description

10.1 Agreement and Plan of Share Exchange dated December 29, 2010.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned.

Dated: September 6, 2011

APERTURE HEALTH, INC. By: /s/ Jim Hennig Name: Jim Hennig Title: President

Filing Compare · Aperture Health, Inc.